Table 7.
Death on day 28 |
ICU |
Need for oxygen |
||||
---|---|---|---|---|---|---|
Best model | p | Best model | p | Best model | p | |
Variant: Omicron | 0.53 [0.37-0.76] | 0.001 | 0.19 [0.12-0.28] | <0.001 | 0.50 [0.38-0.67] | <0.001 |
Sex: male | 1.66 [1.15-2.41] | 0.007 | 1.37 [0.96-1.95] | 0.084 | 1.65 [1.25-2.18] | <0.001 |
Age | 1.07 [1.05-1.08] | <0.001 | 1.04 [1.03-1.04] | <0.001 | ||
Kidney failure | 2.32 [1.46-3.67] | <0.001 | 0.41 [0.15-0.93] | 0.050 | ||
HTA | 1.28 [0.87-1.90] | 0.211 | ||||
Immunosuppressed | 2.21 [1.30-3.66] | 0.003 | 0.79 [0.31-1.83] | 0.593 | 1.56 [1.05-2.33] | 0.028 |
Previous SARS-CoV-2 infection | 0.14 [0.01-0.67] | 0.053 | 0.10 [0.01-0.50] | 0.028 | 0.08 [0.02-0.26] | <0.001 |
Vaccination | 0.45 [0.30-0.66] | <0.001 | 0.26 [0.17-0.39] | <0.001 | 0.20 [0.14-0.28] | <0.001 |
Solid cancer for <3 mo | 5.61 [2.53-12.57] | <0.001 | 0.41 [0.09-1.31] | 0.174 | ||
Overweight | 1.72 [1.10-2.77] | 0.021 | 1.63 [1.17-2.27] | 0.004 | ||
At least one comorbidity | 1.68 [0.84-3.45] | 0.146 | 1.61 [0.97-2.67] | 0.064 | ||
O2 treatment at home | 2.86 [1.05-9.28] | 0.053 | ||||
Interaction vaccination × immunosuppresseda | 2.95 [1.03-8.87] | 0.047 | ||||
Interaction vaccination × previous COVID-19b | 5.60 [1.21-28.49] | 0.030 |
In the model for ICU, a significant and positive interaction was found between being vaccinated and being immunosuppressed, which means that the protective effect of vaccination on the risk of ICU admission decreases among immunosuppressed patients.
In the model for O2 need, a significant and positive interaction was found between being vaccinated and having a previous SARS-CoV-2 infection, which means that the effect of vaccination was decreased among patients having previously had SARS-CoV-2 infection. In addition, a trend towards the interaction between being vaccinated and being immunosuppressed was found, similar to the ICU model, but was not significant (p 0.08), which suggests an effect comparable to the ICU model. ICU, intensive care unit; HTA, Hypertension.